Medicare Enrolled

Dr. Joel Gellman, MD

Cardiovascular Disease · Fort Lauderdale, FL
Practice pattern: Electrophysiology & Device— Practice focused on heart rhythm disorders and cardiac device management
Speaking/Promotional
6405 N FEDERAL HWY STE 200, Fort Lauderdale, FL 33308
9547768550
In practice since 2005 (20 years)
NPI: 1508855339 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Gellman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gellman? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Gellman

Dr. Joel Gellman is a cardiovascular disease in Fort Lauderdale, FL, with 20 years in practice. Based on federal Medicare data, Dr. Gellman performed 2,471 Medicare services across 1,764 unique beneficiaries.

Between the years covered by Open Payments, Dr. Gellman received a total of $222,082 from 18 pharmaceutical and/or device companies across 431 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Gellman is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 48% volume in FL$ $222,082 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,471
Medicare services
Top 48% in FL for cardiovascular disease
1,764
Unique beneficiaries
$64
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~124 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
EKG interpretation and report849$7$12
Electrocardiogram (EKG), 12-lead401$11$60
Office visit, established patient (30-39 min)278$91$523
Hospital follow-up visit, moderate complexity253$65$327
Regadenoson injection (Lexiscan) for heart stress test144$44$248
Technetium tc-99m tetrofosmin, diagnostic, per study dose98$354$1,122
Echocardiogram, transthoracic80$150$789
Office visit, established patient, complex (40-54 min)66$132$731
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician61$50$285
Initial hospital admission, high complexity54$136$716
Nuclear medicine studies of heart muscle at rest and with stress and spect52$347$1,768
Initial hospital admission, moderate complexity50$106$539
New patient office visit (45-59 min)39$119$688
Hospital follow-up visit, high complexity32$95$491
New patient office visit, complex (60-74 min)14$156$907
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
3.2% high complexity
10.4% medium
86.4% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$222,082
Total received (2018-2024)
Avg $31,726/year across 7 years
Top 2% in FL for cardiovascular disease
18
Companies
431
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$215,006 (96.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$4,989 (2.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,087 (0.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$4,812
2023
$1,016
2022
$2,997
2021
$15,109
2020
$38,994
2019
$125,694
2018
$33,460

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amarin Pharma Inc.
$109,736
Novartis Pharmaceuticals Corporation
$76,103
AstraZeneca Pharmaceuticals LP
$23,160
Boston Scientific Corporation
$6,859
Relypsa, Inc.
$2,936
AGEPHA Pharma FZ LLC
$2,053
Astellas Pharma US Inc
$238
Edwards Lifesciences Corporation
$180
Abbott Laboratories
$161
Medtronic, Inc.
$130
BOSTON SCIENTIFIC CORPORATION
$121
Medtronic Vascular, Inc.
$98
Bayer Healthcare Pharmaceuticals Inc.
$83
Actelion Pharmaceuticals US, Inc.
$80
Boehringer Ingelheim Pharmaceuticals, Inc.
$62
PFIZER INC.
$33
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$29
Merck Sharp & Dohme LLC
$22
Top 3 companies account for 94.1% of total payments
Associated products mentioned in payments ›
BRILINTA · Claria MRI · EMBLEM · ENTRESTO · FARXIGA · GENERAL THERAPIES · Kerendia · LEQVIO · LODOCO · LUX DX · LifeVest · Micra · NAVITOR · OPSUMIT · PRADAXA · RESONATE · RESONATE EL ICD VR · VERQUVO · VIGILANT X4 CRT-D · VYNDAQEL · Vascepa · Veltassa
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (97%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in cardiovascular disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 2% for cardiovascular disease in FL.

Equivalent to $8,988 per 100 Medicare services performed
Looking for a cardiovascular disease in Fort Lauderdale?
Compare cardiovascular diseases in the Fort Lauderdale area by procedure volume, costs, and industry payment transparency.
Browse cardiovascular diseases nearby

Geographic Context

Cardiovascular Diseases within 10 mi
318
Per 100K population
16.3
County median income
$74,534
Nearest hospital
HOLY CROSS HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Gellman is a electrophysiology & device specialist, with moderate Medicare volume, and high industry engagement (speaking/promotional, top 2%), with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Gellman experienced with ekg interpretation and report?
Based on Medicare claims data, Dr. Gellman performed 849 ekg interpretation and report services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Gellman receive payments from pharmaceutical companies?
Yes. Dr. Gellman received a total of $222,082 from 18 companies across 431 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gellman's costs compare to other cardiovascular diseases in Fort Lauderdale?
Dr. Gellman's average Medicare payment per service is $64. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gellman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →